Clinical Trials Browser

Recurrence × veliparib × Clear all

NCT01199224 2017-11-21

To Determine the Food Effect and Bioavailability of Three Formulations of Veliparib in Subjects With Solid Tumors

Phase 1 Completed

Recurrence

NCT01472783 2016-11-16

Veli-BRCA

Phase 1/2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

NCT01193140 2012-11-21

To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors

Phase 2 Completed

Neoplasms, Recurrence